Drug Pipeline

M-M-R II vaccine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
3
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06824181 Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and… Pneumococcal Immunization Active, Not Recruiting
NCT06824194 Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From… Pneumococcal Immunization Active, Not Recruiting
NCT06736041 Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy… Pneumococcal Immunization Active, Not Recruiting
Sponsors Running M-M-R II vaccine Trials
Sanofi (2) Sanofi Pasteur, a Sanofi Company (1)
Get alerts when M-M-R II vaccine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free